TELL : +91 0 99 08 87 07 06

 Mcmed International ®: Largest Journal Publication in world

International Journal of Advances In Case Reports

Volume 11, Issue 1, 2024
Mcmed International
International Journal of Advances In Case Reports
Issn
XXX-XXXX (Print), 2349 - 8005 (Online)
Frequency
bi-annual
Email
editorijacr@mcmed.us
Journal Home page
http://mcmed.us/about/ijacr
Recommend to
A Friend  | A librarian
Purchase
Purchase Issue
Abstract
Title
PRESCRIPTION PATTERN ANALYSIS OF ANTIHYPERTENSIVES IN A TERTIARY CARE HOSPITAL
Author
Dasaradhi Ch, Revathi K, Kiranmai Y, Prasanthi B, Tejaswini N
Email
dasaradhi111@gmail.com
keyword
Beta Blockers, Cardiovascular Risk, ARB’s, Prescription Pattern
Abstract
Hypertension is a common disease that is simply defined as persistently elevated arterial blood pressure (BP). Although elevated BP was perceived to be “essential” for adequate perfusion of essential organs during the early and middle 1900s, now it is identified as a major global health problem for cardiovascular diseases like Stroke, Arrhythmias, Renal failure, CHF, etc. The World Health Organization also considers elevated blood pressure (BP) as the most important risk factor for cardiovascular outcomes and carries a high health burden in terms of morbidity and mortality worldwide. Numerous clinical trials have shown that lowering blood pressure (BP) reduces CV risk by 20% - 25% for myocardial infarction, 35%-40% for stroke and by 50% for heart failure. There is a strong positive relationship between blood pressure level and cardiovascular disease risks among general population. Despite of this association, some patients with hypertension do not experience CV events during long life spans and CV events are observed to occur in normotensive individuals also. Reduction of systolic BP of just 2 mmHg can reduce the risk of CVD by 7–10%. In the present study it was observed that most of the patients were prescribed with dual therapy when compared to mono, triple and quadruple therapy. Beta blockers were most prescribed class of anti-hypertensives for hypertensive patients in monotherapy. In dual therapy beta blockers and ARB’s was the most prescribed combination
Download Broucher
Back to Top >>>>